Follicular lymphoma trials in Hong Kong

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  Where

  Hong Kong

  Age

  18 years to 130 years

  People

  1,018 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06549595 · EU 2023-510098-33-01
• Phase 2Taking people
  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Where

  Hong Kong, Shatin

  Age

  18 years and over

  People

  270 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06526793 · EU 2023-505789-27-00